Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2019 Jun 1;17(6):721-749.
doi: 10.6004/jnccn.2019.0028.

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Martin S Tallman  1 , Eunice S Wang  2 , Jessica K Altman  3 , Frederick R Appelbaum  4 , Vijaya Raj Bhatt  5 , Dale Bixby  6 , Steven E Coutre  7 , Marcos De Lima  8 , Amir T Fathi  9 , Melanie Fiorella  10 , James M Foran  11 , Aric C Hall  12 , Meagan Jacoby  13 , Jeffrey Lancet  14 , Thomas W LeBlanc  15 , Gabriel Mannis  7 , Guido Marcucci  16 , Michael G Martin  17 , Alice Mims  18 , Margaret R O'Donnell  16 , Rebecca Olin  19 , Deniz Peker  20 , Alexander Perl  21 , Daniel A Pollyea  22 , Keith Pratz  23 , Thomas Prebet  24 , Farhad Ravandi  25 , Paul J Shami  26 , Richard M Stone  27 , Stephen A Strickland  28 , Matthew Wieduwilt  10 , Kristina M Gregory; OCN  29 ; Lydia Hammond  29 , Ndiya Ogba  29
Affiliations
Practice Guideline

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Martin S Tallman et al. J Natl Compr Canc Netw. .

Abstract

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources